Funding facilitates access to European proteomics facilities
EMBL-EBI and collaborators awarded grant for mass spectrometry-based proteomics research
Summary
- The European Union has awarded ten million euro to a consortium of 18 European research groups focusing on proteomics
- Proteomics is the large-scale study of proteins and their role in living organisms
- Proteomics can give researchers new insights on how biological systems work and the role they play in health
January 10, Cambridge – The European Union has awarded ten million euro to a consortium of 18 European research groups, including the Proteomics team at EMBL’s European Bioinformatics Institute (EMBL-EBI). The project started on January 1, 2019, and will run for four years.
The consortium, called the European Proteomics Initiative Consortium (EPIC-XS) will support researchers by providing them with access to state of the art proteomics equipment.
This initiative is a follow-up of the previous European proteomics infrastructure project PRIME-XS, completed in 2015, in which EMBL-EBI also participated. EPIC-XS will again provide access to proteomics facilities throughout Europe, supporting and expanding the European proteomics community through its expertise in proteomics.
Read the full press release here on the Utrecht University news website.
Edit
